Effects of humidity on the dried-droplet sample preparation for MALDI-TOF MS peptide profiling

Clinica Chimica Acta

Volumn 411, Issue 23-24, 2010, Pages 2109-2111

  Umemura, Hiroshi ^a   Kodera, Yoshio ^a   Nomura, Fumio ^b  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CLINICAL ASSESSMENT; COMPUTER PROGRAM; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL DISPLAY; HIGH THROUGHPUT SCREENING; HUMAN; HUMIDITY; INTERMETHOD COMPARISON; LETTER; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; REPRODUCIBILITY; SIGNAL NOISE RATIO; X RAY DIFFRACTION;

ADULT; ANALYTIC SAMPLE PREPARATION METHODS; BLOOD SPECIMEN COLLECTION; HUMANS; HUMIDITY; MALE; PEPTIDE MAPPING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77957755377     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.08.010     Document Type: Letter

References (19)

1. Thiede B., Hohenwarter W., Krah A., et al. Peptide mass fingerprinting. Methods 2005, 35:237-247.
2. Hu S., Loo J.A., Wong D.T. Human body fluid proteome analysis. Proteomics 2006, 6:6326-6353.
3. Wu C.I., Tsai C.C., Lu C.C., et al. Diagnosis of occult blood in human feces using matrix-assisted laser desorption ionization/time-of-flight mass spectrometry. Clin Chim Acta 2007, 384:86-92.
4. Deng B., Dong Z., Liu Y., et al. Effects of pretreatment protocols on human amniotic fluid protein profiling with SELDI-TOF MS using protein chips and magnetic beads. Clin Chem Acta 2010, 411:1051-1057.
5. Hortin G.L. The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. Clin Chem 2006, 52:1223-1237.
6. Albrethsen J. Reproducibility in protein profiling by MALDI-TOF mass spectrometry. Clin Chem 2007, 53:852-858.
7. Vorm O., Roepstorff P., Mann M. Improved resolution and very high sensitivity in MALDI-TOF of matrix surfaces made by fast evaporation. Anal Chem 1994, 66:3281-3287.
8. Thomas H., Havlis J., Peychl J., Shevchenko A. Dried-droplet probe preparation on AnchorChip targets for navigating the acquisition of matrix-assisted laser desorption/ionization time-of-flight spectra by fluorescence of matrix/analyte crystals. Rapid Commun Mass Spectrom 2004, 18:923-930.
9. Gobom J., Schuerenberg M., Mueller M., Theiss D., Lehrach H., Nordhoff E. Alpha-cyano-4-hydroxycinnamic acid affinity sample preparation. A protocol for MALDI-MS peptide analysis in proteomics. Anal Chem 2001, 73:434-438.
10. Xiang F., Beavis R.C. A method to increase contaminant tolerance in protein matrix-assisted laser desorption/ionization by the fabrication of thin protein-doped polycrystalline films. Rapid Commn Mass Spectrom 1994, 9:199-204.
11. Li L., Golding R.E., Whittal R.M. Analysis of single mammalian cell lysates by mass spectrometry. J Am Chem Soc 1996, 118:11662-11663.
12. Zhang X., Shi L., Shu S., et al. An improved method of sample preparation on AnchorChip targets for MALDI-MS and MS/MS and its application in the liver proteome project. Proteomics 2007, 7:2340-2349.
13. Garaguso I., Borlak J. Matrix layer sample preparation: an improved MALDI-MS peptide analysis method for proteomic studies. Proteomics 2008, 8:2583-2595.
14. Kamada K., Yoshimura S., Murata M., et al. Characterization and monitoring of pseudopolymorphs in manufacturing process by NIR. Int J Pharm 2009, 368:103-108.
15. West-Norager M., Kelstrup C.D., Schou C., Hogdall E.V., Hogdall C.K., Heegaard N.H. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 847:30-37.
16. Umemura H., Nezu M., Kodera Y., et al. Effects of the time intervals between venipuncture and serum preparation for serum peptidome analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chim Acta 2009, 406:179-180.
17. Sogawa K., Satoh M., Kodera Y., Tomonaga T., Iyo M., Nomura F. A search for novel markers of alcohol abuse using magnetic beads and MALDI-TOF/TOF mass spectrometry. Proteomics Clin Appl 2009, 3:821-828.
18. Sawai S., Umemura H., Mori M., et al. Serum levels of complement C4 fragments correlate with disease activity in multiple sclerosis: proteomic analysis. J Neuroimmunol 2010, 218:112-115.
19. Baechle D., Sparbier K., Dihazi H., et al. Towards stable diagnostic setups in clinical proteomics: absolute quantitation of peptide biomarkers using MALDI-TOF-MS. Proteomics Clin Appl 2007, 1:1280-1284.